A systematic review of current and emerging approaches in the field of larynx preservation

Radiother Oncol. 2014 Jan;110(1):16-24. doi: 10.1016/j.radonc.2013.08.016. Epub 2013 Oct 15.

Abstract

Treatment options targeting laryngeal preservation include conservative surgery, concurrent chemo-radiotherapy, induction chemotherapy (IC) followed by radiotherapy (RT), and alternating chemo-radiation. The goal of this paper was to perform a systematic review of randomized clinical trials (RCTs) on current and emerging approaches in the field of larynx preservation. The search identified 36 papers of which 27 did not fall within the inclusion criteria (i.e. non-RCTs). IC followed by RT has been shown to allow laryngeal preservation in about two-thirds of pts with locally advanced laryngeal or hypopharyngeal cancer without compromising survival. IC is regarded as the landmark treatment of non-surgical larynx preservation approaches. Concomitant and alternating chemoradiotherapy treatments are also acceptable in larynx preservation.

Keywords: Concomitant chemoradiotherapy; Induction chemotherapy; Larynx conservation; Larynx preservation.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / radiotherapy
  • Carcinoma, Squamous Cell / surgery
  • Carcinoma, Squamous Cell / therapy
  • Chemoradiotherapy
  • Head and Neck Neoplasms / drug therapy
  • Head and Neck Neoplasms / radiotherapy
  • Head and Neck Neoplasms / surgery
  • Head and Neck Neoplasms / therapy
  • Humans
  • Hypopharyngeal Neoplasms / drug therapy
  • Hypopharyngeal Neoplasms / radiotherapy
  • Hypopharyngeal Neoplasms / surgery
  • Hypopharyngeal Neoplasms / therapy*
  • Laryngeal Neoplasms / drug therapy
  • Laryngeal Neoplasms / radiotherapy
  • Laryngeal Neoplasms / surgery
  • Laryngeal Neoplasms / therapy*
  • Larynx / drug effects
  • Larynx / physiology*
  • Larynx / radiation effects
  • Larynx / surgery
  • Organ Sparing Treatments / methods*
  • Randomized Controlled Trials as Topic
  • Squamous Cell Carcinoma of Head and Neck